These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16377719)

  • 1. Different modes of action of naphthyridones in gram-positive and gram-negative bacteria.
    Buurman ET; Johnson KD; Kelly RK; MacCormack K
    Antimicrob Agents Chemother; 2006 Jan; 50(1):385-7. PubMed ID: 16377719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trovafloxacin: in vitro activity, pharmacokinetics, and clinical experience. Introduction.
    Moellering RC
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):403-4. PubMed ID: 9758282
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro activity of faropenem compared with eight agents against fourteen Gram-positive and Gram-negative bacteria by time-kill.
    Credito KL; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 2003 Jun; 51(6):1437-9. PubMed ID: 12746376
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacokinetics of trovafloxacin: its clinical significance].
    Clara LO; Biglia MA
    Medicina (B Aires); 1999; 59 Suppl 1():17-22. PubMed ID: 10436550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tigecycline: first of a new class of antimicrobial agents.
    Rose WE; Rybak MJ
    Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel inhibitors of bacterial protein synthesis: structure-activity relationships for 1,8-naphthyridine derivatives incorporating position 3 and 4 variants.
    Clark RF; Wang S; Ma Z; Weitzberg M; Motter C; Tufano M; Wagner R; Gu YG; Dandliker PJ; Lerner CG; Chovan LE; Cai Y; Black-Schaefer CL; Lynch L; Kalvin D; Nilius AM; Pratt SD; Soni N; Zhang T; Zhang X; Beutel BA
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3299-302. PubMed ID: 15149694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial activity of enoxacin.
    Nicoletti G; Caccamo F; Speciale A
    J Chemother; 1989 Jul; 1(4 Suppl):143-4. PubMed ID: 16312344
    [No Abstract]   [Full Text] [Related]  

  • 8. Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy.
    Roveta S; Marchese A; Debbia EA
    Chemotherapy; 2008; 54(1):43-9. PubMed ID: 18073470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postantibiotic effect of trovafloxacin against gram-positive and -negative organisms.
    Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1503-5. PubMed ID: 9624503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabrication of monodisperse silica-polymer core-shell nanoparticles with excellent antimicrobial efficacy.
    Jang J; Kim Y
    Chem Commun (Camb); 2008 Sep; (34):4016-8. PubMed ID: 18758611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antimicrobial activity of novel 2-thiazolylimino-5-arylidene-4-thiazolidinones.
    Vicini P; Geronikaki A; Anastasia K; Incerti M; Zani F
    Bioorg Med Chem; 2006 Jun; 14(11):3859-64. PubMed ID: 16488614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis.
    Alhanout K; Brunel JM; Raoult D; Rolain JM
    J Antimicrob Chemother; 2009 Oct; 64(4):810-4. PubMed ID: 19666647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial and cytotoxic constituents from the seeds of Annona squamosa.
    Mukhlesur Rahman M; Parvin S; Ekramul Haque M; Ekramul Islam M; Mosaddik MA
    Fitoterapia; 2005 Jul; 76(5):484-9. PubMed ID: 15964712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoronaphthyridines and -quinolones as antibacterial agents. 5. Synthesis and antimicrobial activity of chiral 1-tert-butyl-6-fluoro-7-substituted-naphthyridones.
    Di Cesare P; Bouzard D; Essiz M; Jacquet JP; Ledoussal B; Kiechel JR; Remuzon P; Kessler RE; Fung-Tomc J; Desiderio J
    J Med Chem; 1992 Oct; 35(22):4205-13. PubMed ID: 1433222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of in-vitro and in-vivo antibacterial activity of tosufloxacin tosilate.
    Yamaguchi K
    J Infect Chemother; 2001 Dec; 7(4):205-17. PubMed ID: 11810586
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimicrobial activity of extractives of Solidago microglossa.
    Morel AF; Dias GO; Porto C; Simionatto E; Stuker CZ; Dalcol II
    Fitoterapia; 2006 Sep; 77(6):453-5. PubMed ID: 16843619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hansch analysis of veratric acid derivatives as antimicrobial agents.
    Narasimhan B; Ohlan S; Ohlan R; Judge V; Narang R
    Eur J Med Chem; 2009 Feb; 44(2):689-700. PubMed ID: 18597896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases.
    Raja NS
    J Microbiol Immunol Infect; 2007 Feb; 40(1):39-44. PubMed ID: 17332905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacterial type II topoisomerases as targets for antibacterial drugs].
    Pietrusiński M; Staczek P
    Postepy Biochem; 2006; 52(3):271-82. PubMed ID: 17201062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activity of nicotine against a spectrum of bacterial and fungal pathogens.
    Pavia CS; Pierre A; Nowakowski J
    J Med Microbiol; 2000 Jul; 49(7):675-6. PubMed ID: 10882095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.